VCEL insider files to sell 3,433 shares

VCEL (filed by Jonathan D. Siegal) reported a proposed sale of 3,433 shares of Common Stock under Rule 144, with proceeds shown as $130,454.00.

Rhea-AI Filing Summary

VCEL (filed by Jonathan D. Siegal) reported a proposed sale of 3,433 shares of Common Stock under Rule 144, with proceeds shown as $130,454.00. The filing lists several prior issuer-side acquisitions (ESPP purchases and restricted stock vesting) with specific lot sizes and dates.

Insights

Insider Transactions Analyst

Small, routine Rule 144 sale by an insider; not clearly material to company fundamentals.

The filing shows a 3,433-share proposed sale under Rule 144 with proceeds of $130,454.00. Multiple prior acquisitions are listed (ESPP lots and restricted stock vesting), indicating the shares likely derived from compensation and employee purchase plans.

Cash‑flow treatment and any selling plan details are not provided in the excerpt; subsequent filings may show whether the sale closed or was part of a scheduled program.

Key Figures

Shares proposed for sale: 3,433 shares Proceeds shown: $130,454.00 Restricted stock vesting lot: 273 shares +2 more

5 metrics

Shares proposed for sale 3,433 shares Securities Sold During The Past 3 Months; sale date 05/06/2026

Proceeds shown $130,454.00 Amount tied to the 3,433-share sale on 05/06/2026

Restricted stock vesting lot 273 shares Restricted Stock Vesting dated 02/18/2023

Restricted stock vesting lot 568 shares Restricted Stock Vesting dated 09/30/2025

ESPP purchase lots (examples) 130; 140; 107; 109; 95 shares ESPP Purchase dates shown from 12/30/2022 through 12/29/2023

Key Terms

Rule 144, ESPP Purchase, Restricted Stock Vesting, Proceeds

4 terms

Rule 144 regulatory

"Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

ESPP Purchase financial

"ESPP Purchase | Issuer | 12/30/2022 | 130"

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 02/18/2023 | 273"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Proceeds financial

"3433 | 130454.00"

FAQ

What did the VCEL Form 144 disclose about the insider sale?

It disclosed a proposed sale of 3,433 shares for $130,454.00. The Form 144 lists the sale date as 05/06/2026 and identifies the seller as Jonathan D. Siegal. The filing also shows prior ESPP purchases and restricted stock vesting lots.

Who is listed as the seller in the VCEL Form 144?

The seller is Jonathan D. Siegal. The filing gives an address in Cambridge, MA, and lists the security as Common Stock traded on NASDAQ. Additional acquisition lots from ESPP and restricted vesting are included in the filing.

What acquisition lots are shown in the filing that created the holdings?

The filing lists multiple ESPP purchases and restricted stock vesting lots. Examples include ESPP purchases of 130, 140, 107, 109, and 95 shares and restricted vesting of 273 and 568 shares on specified dates.

Does the Form 144 state whether proceeds go to the issuer or selling holder?

The proceeds are shown as $130,454.00 tied to the 3,433-share sale. The excerpt does not state recipient treatment beyond listing the sale; it attributes the transaction to the selling holder, Jonathan D. Siegal.

Is this Form 144 likely material to VCEL shareholders?

This single insider sale appears small relative to typical public floats and is routine in nature. The filing contains transaction-level detail but does not present any new company-level financial metric or governance change.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 12:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001916145
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vericel Corp
SEC File Number	001-35280
Address of Issuer	64 SIDNEY ST. CAMBRIDGE MASSACHUSETTS 02139
Phone	7349305555
Name of Person for Whose Account the Securities are To Be Sold	SIEGAL JONATHAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1422	57591.00	51068228	05/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/30/2022	ESPP Purchase	Issuer			130	12/30/2022	Cash
Common	02/18/2023	Restricted Stock Vesting	Issuer			273	02/18/2023	Compensation
Common	03/31/2023	ESPP Purchase	Issuer			140	03/31/2023	Cash
Common	06/30/2023	ESPP Purchase	Issuer			107	06/30/2023	Cash
Common	09/29/2023	ESPP Purchase	Issuer			109	09/29/2023	Cash
Common	12/29/2023	ESPP Purchase	Issuer			95	12/29/2023	Cash
Common	09/30/2025	Restricted Stock Vesting	Issuer			568	09/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan D. Siegal 64 Sidney Street Cambridge MA 02139	Common	05/06/2026	3433	130454.00

144: Remarks and Signature

Remarks
Date of Notice	05/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jonathan D. Siegal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)